Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Clin Lung Cancer. 2020 Dec 2;22(4):e498–e505. doi: 10.1016/j.cllc.2020.11.006

Table 2:

First course of treatment for all NSCLC by stage at diagnosis

Early Stage (Stage I-II) Locally Advanced (Stage III) Metastatic (Stage IV)
HIV+ N=13 HIV−N=2093 P-value HIV+N=9 HIV−N=1096 P-value HIV+N=13 HIV−N=1998 P-value
Surgery 9 (69%) 1406 (67%) 0.99 1 (11%) 311 (28%) 0.46 0 156 (8%) 0.62
Radiation 4 (31%) 647 (31%) 0.99 6 (67%) 737 (67%) 0.99 4 (31%) 1101 (55%) 0.08
Systemic therapy 3 (23%) 402 (19%) 0.72 6 (67%) 835 (78%) 0.45 7 (54%) 1221 (61%) 0.59